Gene expression classifier predicts for hypoxic modification of radiotherapy with nimorazole in squamous cell carcinomas of the head and neck

Research output: Contribution to journalJournal articleResearchpeer-review

  • Kasper Toustrup
  • Brita Singers Sørensen
  • Pernille Lassen
  • Wiuf, Carsten
  • Jan Alsner
  • Jens Overgaard
To validate the predictive impact of a hypoxia gene expression classifier in identifying patients with head and neck squamous cell carcinoma (HNSCC) having benefit from hypoxic modification of radiotherapy.
Original languageEnglish
JournalRadiotherapy & Oncology
Volume102
Issue number1
Pages (from-to)122-129
Number of pages8
ISSN0167-8140
DOIs
Publication statusPublished - 2012
Externally publishedYes

    Research areas

  • Adult, Aged, Aged, 80 and over, Biopsy, Carcinoma, Squamous Cell, Cell Hypoxia, Chi-Square Distribution, Female, Gene Expression Regulation, Neoplastic, Head and Neck Neoplasms, Humans, Male, Middle Aged, Nimorazole, Predictive Value of Tests, Proportional Hazards Models, Radiation-Sensitizing Agents, Survival Rate, Tumor Markers, Biological

ID: 40763573